News
The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results